Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids
Sponsor: Meharry Medical College
Terminated
IRB Decision
Listed as NCT01311869, this PHASE2 trial focuses on Leiomyoma and remains terminated or withdrawn. Sponsored by Meharry Medical College, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
Dec 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Meharry Medical College
For direct contact, visit the study record on ClinicalTrials.gov .